Schonfeld Strategic Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2M | Sell |
15,528
-19,166
| -55% | -$2.24M | 0.01% | 1071 |
|
|
2026
Q1 | $4.17M | Sell |
34,694
-51,961
| -60% | -$6M | 0.03% | 550 |
|
|
2025
Q4 | $9.12M | Sell |
86,655
-341,110
| -80% | -$32M | 0.04% | 367 |
|
|
2025
Q3 | $35.9M | Buy |
427,765
+377,266
| +747% | +$31.1M | 0.2% | 73 |
|
|
2025
Q2 | $4M | Sell |
50,499
-516,105
| -91% | -$41M | 0.03% | 644 |
|
|
2025
Q1 | $50.9M | Buy |
566,604
+124,962
| +28% | +$11.7M | 0.31% | 34 |
|
|
2024
Q4 | $43.9M | Buy |
441,642
+412,209
| +1,400% | +$42.5M | 0.26% | 49 |
|
|
2024
Q3 | $3.34M | Sell |
29,433
-103,235
| -78% | -$12.3M | 0.02% | 681 |
|
|
2024
Q2 | $16.4M | Buy |
132,668
+66,180
| +100% | +$8.52M | 0.11% | 211 |
|
|
2024
Q1 | $8.77M | Buy |
66,488
+60,806
| +1,070% | +$7.49M | 0.06% | 422 |
|
|
2023
Q4 | $619K | Sell |
5,682
-68,868
| -92% | -$7.15M | ﹤0.01% | 1205 |
|
|
2023
Q3 | $7.67M | Sell |
74,550
-22,903
| -24% | -$2.47M | 0.06% | 425 |
|
|
2023
Q2 | $11.2M | Buy |
97,453
+22,740
| +30% | +$2.58M | 0.1% | 317 |
|
|
2023
Q1 | $7.95M | Buy |
74,713
+39,614
| +113% | +$4.28M | 0.08% | 340 |
|
|
2022
Q4 | $3.89M | Sell |
35,099
-33,007
| -48% | -$3.37M | 0.03% | 559 |
|
|
2022
Q3 | $5.87M | Buy |
68,106
+19,946
| +41% | +$1.78M | 0.05% | 479 |
|
|
2022
Q2 | $4.39M | Sell |
48,160
-36,542
| -43% | -$3.24M | 0.04% | 509 |
|
|
2022
Q1 | $6.95M | Buy |
84,702
+79,302
| +1,469% | +$6.25M | 0.06% | 343 |
|
|
2021
Q4 | $414K | Sell |
5,400
-70,261
| -93% | -$5.6M | ﹤0.01% | 1360 |
|
|
2021
Q3 | $5.68M | Buy |
+75,661
| New | +$5.75M | 0.06% | 397 |
|
|
2021
Q1 | – | Sell |
-145,196
| Closed | -$11.3M | – | 2017 |
|
|
2020
Q4 | $11.3M | Buy |
145,196
+37,279
| +35% | +$2.85M | 0.15% | 184 |
|
|
2020
Q3 | $8.54M | Buy |
107,917
+51,169
| +90% | +$4.01M | 0.16% | 178 |
|
|
2020
Q2 | $4.19M | Buy |
56,748
+19,962
| +54% | +$1.5M | 0.11% | 264 |
|
|
2020
Q1 | $2.7M | Sell |
36,786
-88,079
| -71% | -$6.92M | 0.17% | 140 |
|
|
2019
Q4 | $10.8M | Buy |
124,865
+4,188
| +3% | +$344K | 0.26% | 100 |
|
|
2019
Q3 | $9.69M | Sell |
120,677
-34,893
| -22% | -$2.8M | 0.28% | 102 |
|
|
2019
Q2 | $12.4M | Sell |
155,570
-29,297
| -16% | -$2.24M | 0.44% | 54 |
|
|
2019
Q1 | $14.7M | Buy |
184,867
+35,527
| +24% | +$2.66M | 0.51% | 36 |
|
|
2018
Q4 | $10.9M | Sell |
149,340
-149,087
| -50% | -$10.5M | 0.42% | 52 |
|
|
2018
Q3 | $20.2M | Buy |
298,427
+14,347
| +5% | +$914K | 0.9% | 11 |
|
|
2018
Q2 | $16.5M | Buy |
284,080
+268,217
| +1,691% | +$15.1M | 0.89% | 6 |
|
|
2018
Q1 | $825K | Buy |
+15,863
| New | +$857K | 0.06% | 370 |
|
|
2017
Q4 | – | Sell |
-206,695
| Closed | -$12.6M | – | 827 |
|
|
2017
Q3 | $12.6M | Buy |
206,695
+6,152
| +3% | +$373K | 1.15% | 5 |
|
|
2017
Q2 | $12.3M | Buy |
+200,543
| New | +$12.2M | 1.26% | 5 |
|
|
2017
Q1 | – | Sell |
-36,002
| Closed | -$2.02M | – | 684 |
|
|
2016
Q4 | $2.02M | Buy |
+36,002
| New | +$2.11M | 0.26% | 112 |
|
|
2016
Q3 | – | Sell |
-24,793
| Closed | -$1.36M | – | 494 |
|
|
2016
Q2 | $1.36M | Buy |
+24,793
| New | +$1.32M | 0.31% | 87 |
|
Other funds holding MRK
Schonfeld Strategic Advisors's MRK Position: Q2 2026 in Review
Schonfeld Strategic Advisors reduced its Merck (MRK) stake by 55% in Q2 2026, selling an estimated $2.24M and leaving 15,528 shares worth $2M. The position accounts for 0.01% of the portfolio, ranked #1071.
Schonfeld Strategic Advisors first reported a position in MRK in Q2 2016 and has held it in 36 quarters since. The position peaked at $50.9M in Q1 2025. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Schonfeld Strategic Advisors held 15,528 shares of Merck worth $2M as of Q2 2026.
- Schonfeld Strategic Advisors sold 19,166 Merck shares in Q2 2026, an estimated $2.24M.
- Merck made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1071 holding.
- Schonfeld Strategic Advisors first reported a position in Merck in Q2 2016 and has held it in 36 quarters since.
- Schonfeld Strategic Advisors's Merck position peaked at $50.9M in Q1 2025.
- 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.